مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides.
Normal view MARC view ISBD view

Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides. [electronic resource]

By:
  • Agrawal, S
Contributor(s):
  • Kandimalla, E R
  • Yu, D
  • Hollister, B A
  • Chen, S F
  • Dexter, D L
  • Alford, T L
  • Hill, B
  • Bailey, K S
  • Bono, C P
  • Knoerzer, D L
  • Morton, P A
Producer: 20010607Description: 1061-9 p. digitalISSN:
  • 1019-6439
Subject(s):
  • Animals
  • Antineoplastic Agents, Phytogenic -- therapeutic use
  • Camptothecin -- analogs & derivatives
  • Cyclic AMP-Dependent Protein Kinases -- genetics
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Synergism
  • Enzyme Inhibitors -- therapeutic use
  • Female
  • Humans
  • Irinotecan
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Neoplasms -- drug therapy
  • Nuclear Proteins
  • Oligonucleotides, Antisense -- therapeutic use
  • Proto-Oncogene Proteins -- genetics
  • Proto-Oncogene Proteins c-mdm2
  • Topoisomerase I Inhibitors
  • Treatment Outcome
Online resources:
  • Available from publisher's website
In: International journal of oncology vol. 18
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.
Browse results Close
Previous
Back to results
Next
Close

Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides.

APA

Agrawal S., Kandimalla E. R., Yu D., Hollister B. A., Chen S. F., Dexter D. L., Alford T. L., Hill B., Bailey K. S., Bono C. P., Knoerzer D. L. & Morton P. A. (20010607). Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides. : International journal of oncology.

Chicago

Agrawal S, Kandimalla E R, Yu D, Hollister B A, Chen S F, Dexter D L, Alford T L, Hill B, Bailey K S, Bono C P, Knoerzer D L and Morton P A. 20010607. Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides. : International journal of oncology.

Harvard

Agrawal S., Kandimalla E. R., Yu D., Hollister B. A., Chen S. F., Dexter D. L., Alford T. L., Hill B., Bailey K. S., Bono C. P., Knoerzer D. L. and Morton P. A. (20010607). Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides. : International journal of oncology.

MLA

Agrawal S, Kandimalla E R, Yu D, Hollister B A, Chen S F, Dexter D L, Alford T L, Hill B, Bailey K S, Bono C P, Knoerzer D L and Morton P A. Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides. : International journal of oncology. 20010607.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site